Compared with control cells, mAb NJ001 altered downstream target genes matrix metallopeptidases 7 (MMP‐7) and tissue inhibitor of metalloproteinases 3 (TIMP‐3), both of which regulate cancer invasiveness and metastasis. Here, TIMP3 is linked to cancer.